MCF Advisors’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $916K | Buy |
32,618
+5,442
| +20% | +$145K | 0.04% | 183 |
|
|
2025
Q4 | $677K | Buy |
27,176
+12,596
| +86% | +$318K | 0.04% | 168 |
|
|
2025
Q3 | $372K | Buy |
14,580
+219
| +2% | +$5.41K | 0.02% | 184 |
|
|
2025
Q2 | $348K | Sell |
14,361
-6,118
| -30% | -$143K | 0.02% | 181 |
|
|
2025
Q1 | $519K | Buy |
20,479
+2,582
| +14% | +$67.6K | 0.04% | 141 |
|
|
2024
Q4 | $475K | Sell |
17,897
-511
| -3% | -$13.9K | 0.03% | 152 |
|
|
2024
Q3 | $533K | Buy |
18,408
+2,364
| +15% | +$69K | 0.04% | 138 |
|
|
2024
Q2 | $449K | Sell |
16,044
-5,257
| -25% | -$145K | 0.03% | 145 |
|
|
2024
Q1 | $591K | Sell |
21,301
-1,782
| -8% | -$49.4K | 0.05% | 123 |
|
|
2023
Q4 | $665K | Sell |
23,083
-4,507
| -16% | -$136K | 0.05% | 108 |
|
|
2023
Q3 | $915K | Buy |
27,590
+975
| +4% | +$34.5K | 0.08% | 82 |
|
|
2023
Q2 | $976K | Buy |
26,615
+50
| +0.2% | +$1.95K | 0.09% | 74 |
|
|
2023
Q1 | $1.08M | Buy |
26,565
+1,267
| +5% | +$54.7K | 0.1% | 66 |
|
|
2022
Q4 | $1.3M | Sell |
25,298
-270
| -1% | -$12.9K | 0.13% | 53 |
|
|
2022
Q3 | $1.12M | Buy |
25,568
+7,485
| +41% | +$364K | 0.12% | 55 |
|
|
2022
Q2 | $948K | Buy |
18,083
+321
| +2% | +$16.4K | 0.1% | 63 |
|
|
2022
Q1 | $920K | Buy |
+17,762
| New | +$922K | 0.09% | 68 |
|
|
2021
Q4 | – | Sell |
-18,573
| Closed | -$799K | – | 496 |
|
|
2021
Q3 | $799K | Buy |
18,573
+1,084
| +6% | +$48K | 0.08% | 65 |
|
|
2021
Q2 | $685K | Buy |
17,489
+3,798
| +28% | +$148K | 0.07% | 75 |
|
|
2021
Q1 | $496K | Sell |
13,691
-1,603
| -10% | -$56.9K | 0.06% | 87 |
|
|
2020
Q4 | $563K | Sell |
15,294
-5,626
| -27% | -$206K | 0.07% | 69 |
|
|
2020
Q3 | $728K | Buy |
20,920
+9,753
| +87% | +$342K | 0.1% | 58 |
|
|
2020
Q2 | $346K | Buy |
11,167
+3
| +0% | +$102 | 0.05% | 98 |
|
|
2020
Q1 | $346K | Sell |
11,164
-1,436
| -11% | -$48.9K | 0.06% | 93 |
|
|
2019
Q4 | $468K | Buy |
12,600
+3
| +0% | +$107 | 0.07% | 84 |
|
|
2019
Q3 | $429K | Buy |
12,597
+3
| +0% | +$109 | 0.07% | 86 |
|
|
2019
Q2 | $518K | Sell |
12,594
-182
| -1% | -$7.23K | 0.09% | 76 |
|
|
2019
Q1 | $515K | Sell |
12,776
-1,832
| -13% | -$73.4K | 0.09% | 77 |
|
|
2018
Q4 | $605K | Buy |
14,608
+33
| +0.2% | +$1.37K | 0.12% | 64 |
|
|
2018
Q3 | $609K | Buy |
14,575
+1,397
| +11% | +$53.8K | 0.11% | 64 |
|
|
2018
Q2 | $454K | Buy |
13,178
+25
| +0.2% | +$854 | 0.09% | 76 |
|
|
2018
Q1 | $443K | Sell |
13,153
-420
| -3% | -$14.4K | 0.09% | 72 |
|
|
2017
Q4 | $466K | Sell |
13,573
-2,393
| -15% | -$81.6K | 0.09% | 70 |
|
|
2017
Q3 | $541K | Sell |
15,966
-878
| -5% | -$28.2K | 0.11% | 59 |
|
|
2017
Q2 | $537K | Sell |
16,844
-2,328
| -12% | -$73.4K | 0.11% | 50 |
|
|
2017
Q1 | $622K | Buy |
19,172
+1,768
| +10% | +$55.7K | 0.13% | 44 |
|
|
2016
Q4 | $536K | Sell |
17,404
-258
| -1% | -$7.88K | 0.12% | 49 |
|
|
2016
Q3 | $568K | Sell |
17,662
-3,335
| -16% | -$112K | 0.13% | 52 |
|
|
2016
Q2 | $701K | Buy |
20,997
+3,353
| +19% | +$107K | 0.17% | 46 |
|
|
2016
Q1 | $496K | Sell |
17,644
-1,391
| -7% | -$39.7K | 0.13% | 49 |
|
|
2015
Q4 | $583K | Buy |
19,035
+853
| +5% | +$26.8K | 0.16% | 43 |
|
|
2015
Q3 | $542K | Sell |
18,182
-11,353
| -38% | -$364K | 0.14% | 43 |
|
|
2015
Q2 | $940K | Buy |
29,535
+87
| +0.3% | +$2.83K | 0.24% | 29 |
|
|
2015
Q1 | $972K | Sell |
29,448
-291
| -1% | -$9.25K | 0.24% | 28 |
|
|
2014
Q4 | $879K | Sell |
29,739
-981
| -3% | -$28.1K | 0.24% | 30 |
|
|
2014
Q3 | $936K | Sell |
30,720
-158
| -0.5% | -$4.43K | 0.28% | 34 |
|
|
2014
Q2 | $941K | Buy |
30,878
+460
| +2% | +$13.1K | 0.3% | 28 |
|
|
2014
Q1 | $927K | Buy |
30,418
+3,273
| +12% | +$97.6K | 0.31% | 29 |
|
|
2013
Q4 | $827K | Sell |
27,145
-1,227
| -4% | -$35.7K | 0.29% | 29 |
|
|
2013
Q3 | $865K | Buy |
28,372
+1,082
| +4% | +$29.4K | 0.48% | 23 |
|
|
2013
Q2 | $832K | Buy |
+27,290
| New | +$754K | 0.5% | 21 |
|
Other funds holding PFE
VCM
VPM
MCF Advisors's PFE Position: Q1 2026 in Review
MCF Advisors increased its Pfizer (PFE) stake by 20% in Q1 2026, buying an estimated $145K and bringing the position to 32,618 shares worth $916K. The position accounts for 0.04% of the portfolio, ranked #183.
MCF Advisors first reported a position in PFE in Q2 2013 and has held it in 51 quarters since. The position peaked at $1.3M in Q4 2022. 2,939 funds tracked by Wall St. Rank hold PFE as of Q1 2026.
- MCF Advisors held 32,618 shares of Pfizer worth $916K as of Q1 2026.
- MCF Advisors bought 5,442 Pfizer shares in Q1 2026, an estimated $145K.
- Pfizer made up 0.04% of MCF Advisors's portfolio in Q1 2026, its #183 holding.
- MCF Advisors first reported a position in Pfizer in Q2 2013 and has held it in 51 quarters since.
- MCF Advisors's Pfizer position peaked at $1.3M in Q4 2022.
- 2,939 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.
Based on MCF Advisors's 13F filing for Q1 2026, filed 11 May 2026.